Acitretin, a retinoid-derivative and approved treatment for Psoriasis vulgaris,increases non-amyloidogenic Amyloid-Precursor-Protein-(APP)-processing, prevents Aβ-production and elicits cognitive improvement in AD mouse models. This evidence concerns the gene APP and psoriasis vulgaris.